| DIRECT COMPETITOR COMPARISON | |
| AMRI | CRL | CVD | PRXL | Industry | | Market Cap: | 266.75M | 2.15B | 3.41B | 722.24M | 75.08M | | Employees: | 1,357 | 9,000 | 8,826 | 9,275 | 217 | | Qtrly Rev Growth (yoy): | -22.30% | -13.10% | 5.60% | -3.80% | 11.90% | | Revenue (ttm): | 209.39M | 1.22B | 1.92B | 1.23B | 56.04M | | Gross Margin (ttm): | 27.94% | 36.22% | 30.66% | 30.52% | 35.56% | | EBITDA (ttm): | 23.73M | 284.53M | 324.37M | 127.16M | -2.13M | | Oper Margins (ttm): | 3.22% | 15.76% | 12.45% | 5.84% | -5.87% | | Net Income (ttm): | 5.63M | -567.54M | 180.02M | 38.13M | N/A | | EPS (ttm): | 0.181 | -8.569 | 2.808 | 0.659 | N/A | | P/E (ttm): | 46.57 | N/A | 18.98 | 18.85 | 19.44 | | PEG (5 yr expected): | 28.6 | 1.6 | 1.49 | 0.99 | 1.47 | | P/S (ttm): | 1.30 | 1.78 | 1.80 | 0.60 | 1.80 |
|
| CRL = Charles River Laboratories International Inc. | | CVD = Covance Inc. | | PRXL = Parexel International Corp. | | Industry = Research Services | |
| NEWS ON DIRECT COMPETITORS | |
| • | CRL | | Zacks #5 Rank Additions for Friday
Fri 5:16am -
Zacks.com | | • | CRL | | We Expect Ailing CROs to Recover
Wed, Nov 25 -
Morningstar.com | | • | CRL | | Zacks #5 Rank Additions for Tuesday
Tue, Nov 24 -
Zacks.com | | • | CRL | | China Biotech Week in Review: CROs Consolidating
Sun, Nov 22 -
at Seeking Alpha | | • | CVD | | The Stockpickers: Fund managers hunt small-caps that can grow bigger
Fri, Nov 20 -
at MarketWatch | | • | CVD | | Zacks #5 Rank Additions for Friday
Fri, Nov 20 -
Zacks.com | | • | CVD | | Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
Wed, Nov 18 -
PR Newswire | | • | CVD | | Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
Wed, Nov 18 -
PR Newswire | | • | PRXL | | PAREXEL Experts to Discuss Impact of Pharmacovigilance Trends on Biosimilars and Generics at World Generic Medicines Congress Americas
Wed, Nov 18 -
PR Newswire | | • | PRXL | | Perceptive Informatics Expands Nuclear Imaging Capabilities for Cardiology Trials
Tue, Nov 17 -
PR Newswire | | • | PRXL | | PAREXEL Experts to Discuss Global Capabilities to Meet Urgent Demand For Cardiovascular Treatments at AHA Scientific Sessions
Mon, Nov 16 -
PR Newswire | | • | CVD | | How Do You Say 'Drug Development' in Mandarin?
Thu, Nov 12 -
at Motley Fool | | • | PRXL | | PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Change in Directors or Principal Officers
Thu, Nov 12 -
EDGAR Online | | • | CRL | | Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
Mon, Nov 9 -
Wall Street Transcript | | • | CRL | | Bearish MACD for Charles River
Mon, Nov 9 -
Zacks.com | | • | CRL | | Charles River downgraded by Barclays Capital
Mon, Nov 9 -
Briefing.com | | • | CRL | | Zacks #5 Rank Additions for Monday
Mon, Nov 9 -
Zacks.com | | • | CRL | | CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
Sat, Nov 7 -
EDGAR Online Financials | | • | CRL | | [$$] Garmin Gets Lost As Merck Rises 6.4%
Thu, Nov 5 -
at The Wall Street Journal Online | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
